Nitazenes — a class of highly potent synthetic opioids — are rapidly emerging as a major contributor to the overdose
Nitazenes — a class of highly potent synthetic opioids — are rapidly emerging as a major contributor to the overdose […]
RheumNow
RheumNow
RheumNow
RheumNow Podcast – Ro, Ro, Ro52 (9.12.2025) Dr. Jack Cush reviews the news and journal reports from the past week on
RheumNow Podcast – Ro, Ro, Ro52 (9.12.2025) Dr. Jack Cush reviews the news and journal reports from the past week
RheumNow
Hitting the Target: T2T Therapy in SLE Treat-to-target strategies are not a new concept in rheumatology. It has shown
Hitting the Target: T2T Therapy in SLE Treat-to-target strategies are not a new concept in rheumatology. It has shown https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
RheumNow
There is no criteria for infection-induced Antiphospholipid syndr (APS). aPL & aCL abs have been reported w/ COVID,
There is no criteria for infection-induced Antiphospholipid syndr (APS). aPL & aCL abs have been reported w/ COVID, https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
RheumNow
Definitions for Interstitial Lung Disease: A Consensusfrom the Fleischner Society https://t.co/gEqmkdJLDh https://t.co/8
Definitions for Interstitial Lung Disease: A Consensusfrom the Fleischner Society https://t.co/gEqmkdJLDh https://t.co/8 https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Tue, 09/16/2025 – 11:30 RheumNow Dr.
RheumNow
Call to Update the Classification Criteria in Idiopathic Inflammatory Myopathies (IMM), Why? – EULAR/ACR myositis criter
Call to Update the Classification Criteria in Idiopathic Inflammatory Myopathies (IMM), Why? – EULAR/ACR myositis criter https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Tue, 09/16/2025
RheumNow
GCs have potent anti-inflammatory effects but it’s long term complications can be catastrophic. In SLE pts, it shows
GCs have potent anti-inflammatory effects but it’s long term complications can be catastrophic. In SLE pts, it shows https://pbs.twimg.com/profile_images/1027501556868870145/2culK0bN_normal.jpg john+RNV2@john…
RheumNow
My article 👇 summarizing the 2025 update of EULAR recommendations by @eular_org, presented by Josef Smolen at @APLA
My article 👇 summarizing the 2025 update of EULAR recommendations by @eular_org, presented by Josef Smolen at @APLA https://pbs.twimg.com/profile_images/1800478984926334976/yyyPLP4A_normal.jpg john+RNV2@john…
RheumNow
PsO/PsA patients have an ⬆️ CV risk brought about by traditional and CV risk factors. Do you perform regular CV ri
PsO/PsA patients have an ⬆️ CV risk brought about by traditional and CV risk factors. Do you perform regular CV
RheumNow
A self learning program to train non Rheumatologists to interpret pelvic X-rays and identify sacro-iliitis? It works,
A self learning program to train non Rheumatologists to interpret pelvic X-rays and identify sacro-iliitis? It works, https://pbs.twimg.com/profile_images/1800478984926334976/yyyPLP4A_normal.jpg john+RNV2@john… Tue,
RheumNow
IL-17is demonstrate efficacy in SpA tx Comparable with TNFis & JAKis in terms of achieving ASAS40 response rates IL
IL-17is demonstrate efficacy in SpA tx Comparable with TNFis & JAKis in terms of achieving ASAS40 response rates IL https://pbs.twimg.com/profile_images/1027501556868870145/2culK0bN_normal.jpg
RheumNow
SARD-ILD and serious infection risk: The elephant in the room
SARD-ILD and serious infection risk: The elephant in the room jsparks@bwh.ha… Tue, 09/16/2025 – 08:00
RheumNow
Equal Safety of JAK Inhibitors and TNF Inhibitors
Equal Safety of JAK Inhibitors and TNF Inhibitors jjcush@gmail.com Tue, 09/16/2025 – 08:00
ILD and Mortality in Systemic Autoimmune Rheumatic Diseases
ILD and Mortality in Systemic Autoimmune Rheumatic Diseases tammytilley@gm… Tue, 09/16/2025 – 08:00 Education/ACR/EULAR Other Rheumatoid Arthritis Cardio/Pulmonary Myositis Scleroderma/Raynauds
RheumNow
Evidence of immune ageing detected at the earliest stages of RA. Study of 69 controls, 32 CSA, 44 undiff. arthritis (U
Evidence of immune ageing detected at the earliest stages of RA. Study of 69 controls, 32 CSA, 44 undiff. arthritis
RheumNow
Target trial emulation looked at CV (MACE) events in 18,120 propensity score–matched adults with gout starting allopur
Target trial emulation looked at CV (MACE) events in 18,120 propensity score–matched adults with gout starting allopur https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Mon,
RheumNow
Hospital for Special Surgery (HSS) reports that ear acupuncture applied during hip replacement surgery reduces pain and
Hospital for Special Surgery (HSS) reports that ear acupuncture applied during hip replacement surgery reduces pain and https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Mon,
RheumNow
RCT of 800 adults w/ Chronic LBP, acupuncture (AP) was compared usual care or AP +/- added maintenance found that acup
RCT of 800 adults w/ Chronic LBP, acupuncture (AP) was compared usual care or AP +/- added maintenance found that
RheumNow
SLE and Osteoporosis Systemic Lupus Erythematosus (SLE) is a multisystem autoimmune disease that can present with a va
SLE and Osteoporosis Systemic Lupus Erythematosus (SLE) is a multisystem autoimmune disease that can present with a va https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
RheumNow
SMART study – Single vs. Split Dose Methotrexate in RA Split dose weekly, oral methotrexate (MTX) was shown to be supe
SMART study – Single vs. Split Dose Methotrexate in RA Split dose weekly, oral methotrexate (MTX) was shown to be
RheumNow
Future Perspectives of Rheumatoid Arthritis Dr. Kuni Yamaoka, shares highlights from the Future Perspectives of Rheuma
Future Perspectives of Rheumatoid Arthritis Dr. Kuni Yamaoka, shares highlights from the Future Perspectives of Rheuma https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Mon, 09/15/2025
ILD: Diagnosis and Subtypes (Part Two)
ILD: Diagnosis and Subtypes (Part Two) tammytilley@gm… Mon, 09/15/2025 – 10:08 Image By downloading this material, I acknowledge that it
RheumNow
In lupus patients presenting with demyelinating symptoms, consider a probable disease overlap between NPSLE and NMOSD.
In lupus patients presenting with demyelinating symptoms, consider a probable disease overlap between NPSLE and NMOSD. https://pbs.twimg.com/profile_images/1027501556868870145/2culK0bN_normal.jpg john+RNV2@john… Mon, 09/15/2025
RheumNow
What are the Pros and Cons of autologous CAR T cell therapy? Summary slide from Georg Schett who also mentioned the exc
What are the Pros and Cons of autologous CAR T cell therapy? Summary slide from Georg Schett who also mentioned
RheumNow
Juvenile Lupus: some new mechanistic data Circulating Treg population are expanded in SLE and in particular in Lupus Ne
Juvenile Lupus: some new mechanistic data Circulating Treg population are expanded in SLE and in particular in Lupus Ne https://pbs.twimg.com/profile_images/1800478984926334976/yyyPLP4A_normal.jpg
RheumNow
Different B cells depletion strategies in SARDs highlighted by Georg Schett From low and short lived depletion achieved
Different B cells depletion strategies in SARDs highlighted by Georg Schett From low and short lived depletion achieved https://pbs.twimg.com/profile_images/1800478984926334976/yyyPLP4A_normal.jpg john+RNV2@john…
RheumNow
PAH, when associated with ILD in CTD, worsens prognosis, and poses challenges for treatment Summary of when PAH should
PAH, when associated with ILD in CTD, worsens prognosis, and poses challenges for treatment Summary of when PAH should https://pbs.twimg.com/profile_images/1800478984926334976/yyyPLP4A_normal.jpg